# Premarket Notification [510(k)] Summary

,JUL 2 1 2006

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92 The assigd 510(k) number is: k06 0205

Company: Horiba ABX Parc Euromédecine Rue du Caducée - BP 7290 34184 Montpellier cedex 4 FRANCE Telephone: + (33) 4 67 14 73 20 Fax: $^ +$ (33) 4 67 14 15 17

Contact Person: Tim Lawton (tlawton@fr.abx.fr)

Date Prepared: $2 0 ^ { \mathrm { t h } }$ January 2006

# Device Names:

The following reagents, controls & calibrators are for use in conjunction with the ABX PENTRA 400, cleared to market under K052007.

# REAGENTS :

# ABX PENTRA ALP CP

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
ALP - Alkaline phosphatase   
Class II   
$\ S 8 6 2 . 1 0 5 0$ : Alkaline phosphatase Test System   
CJE ; nitrophenylphosphate, alkaline phosphatase or isoenzymes

# ABX PENTRA Calcium CP

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
Calcium   
Class II   
$\ S 8 6 2 . 1 1 4 5$ : Calcium Test System   
CIC ; cresolphthalein complexone, calcium

# ABX PENTRA CO2 RTU

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
carbon dioxide   
Class II   
$\ S 8 6 2 . 1 1 6 0$ : Bicarbonate/carbon dioxide Test System   
KHS ; enzymatic, carbon-dioxide   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA Creatinine CP

Creatinine   
Class II   
$\ S 8 6 2 . 1 2 2 5$ : Creatinine Test System   
CGX ; alkaline picrate, colorimetry, creatinine   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA Iron CP

Iron   
Class I   
$\ S 8 6 2 . 1 4 1 0 : \mathrm { I I }$ on (non-heme) Test System JIY ; photometric method, iron (non-heme)   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA Magnesium RTU

Magnesium   
Class II   
$\ S 8 6 2 . 1 4 9 5 : \mathbb { N }$ lagnesium Test System JGJ ; photometric method, magnesium   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA Phosphorus CP

Phosphorus   
Class II   
$\ S 8 6 2 . 1 5 8 0$ : Phosphorus (inorganic) Test System   
CEO ; phosphomolybdate (colorimetric), inorganic phosphorus   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA Urea CP

Urea   
Class II   
$\ S 8 6 2 . 1 7 7 0$ : Urea nitrogen Test System   
CDQ ; urease and glutamic dehydrogenase, urea nitrogen   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA Uric Acid CP

Uric Acid   
Class I   
$\ S 8 6 2 . 1 7 7 5$ : Uric acid Test System   
KNK ; acid, uric, uricase (colorimetric)

# CONTROLS :

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA CO2 Control

CO2 Control   
Class I   
$\ S 8 6 2 . 1 6 6 0 :$ Quality control material (assayed and unassayed) JJX ; single (specified) analyte controls (assayed and unassayed)   
Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:

# ABX PENTRA N Control (K052007)

N Control   
Class I   
$\ S 8 6 2 . 1 6 6 0 :$ Quality control material (assayed and unassayed)   
JJY ; Multi-Analyte Controls, All Kinds (Assayed and Unassayed)

# ABX PENTRA P Control (K052007)

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
P Control   
Class I   
$\ S 8 6 2 . 1 6 6 0$ : Quality control material (assayed and unassayed)   
JJY ; Multi-Analyte Controls, All Kinds (Assayed and Unassayed)

# Calibrators :

# ABX PENTRA Multical (K052007)

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
Multical   
Class II   
$\ S 8 6 2 . 1 1 5 0$ : Calibrator   
JIX ; Calibrator, Multi-Analyte Mixture

# ABX PENTRA CO2 Cal

Trade/Proprietary Name:   
Common or Usual Name:   
Device Class   
Classification Name:   
Product Code:   
CO2 Calibrator   
Class II   
$\ S 8 6 2 . 1 1 5 0 :$ Calibrator   
JIT ; calibrator, secondary

# Substantial Equivalence:

The data and information supplied in this submission demonstrates substantial equivalence to their respective predicate devices :

<table><tr><td rowspan=1 colspan=1>Submission device</td><td rowspan=1 colspan=1>Substantially equivalentpredicate device</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA ALP CP</td><td rowspan=1 colspan=1>K801242</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Calcium CP</td><td rowspan=1 colspan=1>K883453</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA CO2 RTU</td><td rowspan=1 colspan=1>K031879</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Creatinine CP</td><td rowspan=1 colspan=1>K941837</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Iron CP</td><td rowspan=1 colspan=1>K864819</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Magnesium RTU</td><td rowspan=1 colspan=1>K901758</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Phosphorus CP</td><td rowspan=1 colspan=1>K883962</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Urea CP</td><td rowspan=1 colspan=1>K954000</td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA Uric Acid CP</td><td rowspan=1 colspan=1>K922762</td></tr><tr><td></td><td></td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA C02 Cal</td><td rowspan=1 colspan=1>K031879</td></tr><tr><td></td><td></td></tr><tr><td rowspan=1 colspan=1>ABX PENTRA CO2 Control</td><td rowspan=1 colspan=1>K891475</td></tr></table>

# Description:

All the reagents, controls and calibrators included in this submission are for use on the ABX PENTRA 400 (K052007), which is a discrete photometric benchtop clinical chemistry analyzer.

The ABX PENTRA 400 offers both Closed and Open channels for a multitude of parameters (clinical chemistry, DAT, TDM, plasma protein, hemostasis, optional ISE module).

All reagents described in this submission are for the quantitative in-vitro determination of their respective parameters

# Intended Use :

All reagents in this submission are intended for use on the ABX PENTRA 400 for the quantitative in-vitro determination of their respective analytes (ALP - Alkaline Phosphatase, Calcium, C02, Creatinine, Iron, Magnesium, Phosphorus, Urea / Blood Urea Nitrogen, Uric Acid) using human serum and plasma.

The controls and calibrators are intended for use in association with the above reagents.

# Discussion of Performance Data:

<table><tr><td colspan="2">ABX PENTRA ALP CP :</td></tr><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>6 U/I</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 4.36%</td></tr><tr><td rowspan="2">Measuring range</td><td>6 U/1 - 1500 U/l</td></tr><tr><td>Automatic post-dilution : 6000 U/I</td></tr><tr><td>Correlation (n=105)</td><td>Y = 1.07 x - 3.93 with a correlation coefficient r2 = 0.998.</td></tr><tr><td>Calibration stability</td><td>7 hours</td></tr><tr><td>Reagent stability</td><td>closed stability: 18 months at 2-8°C on-board stability (refrigerated area): 29 days</td></tr></table>

<table><tr><td colspan="2">ABX PENTRA Calcium CP :</td></tr><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>0.16 mg/dl</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 1.67%</td></tr></table>

# ABX PENTRA Calcium CP :

<table><tr><td>Measuring range</td><td>0.16 mg/dl - 20.1 mg/dl Automatic post-dilution : 40.2 mg/dl</td></tr><tr><td>Correlation (n=95)</td><td>Y = 1.15 x - 1.12 with a correlation coefficient r² = 0.950.</td></tr><tr><td>Calibration stability</td><td>6 hours</td></tr><tr><td>Reagent stability</td><td>closed stability: 24 months at 2-8°C on-board stability (refrigerated area): 14 days</td></tr></table>

# ABX PENTRA CO2 RTU :

<table><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>1.8 mmol/l</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 7.7%</td></tr><tr><td>Measuring range</td><td>1.8 mmol/l  60.8 mmol/l</td></tr><tr><td></td><td>Automatic post-dilution : 121.6 mmol/l</td></tr><tr><td>Correlation (n=97)</td><td>Y = 0.85 x + 0.3 with a correlation coefficient r2 = 0.976.</td></tr><tr><td>Calibration stability</td><td>1 day</td></tr><tr><td>Reagent stability</td><td>closed stability: 16 months at 2-8°C on-board stability (refrigerated area): 28 days</td></tr></table>

# ABX PENTRA Creatinine CP :

<table><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>0.11 mg/dl</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 3.69%</td></tr><tr><td>Measuring range</td><td>0.1 1 mg/dl - 15.8 mg/dl</td></tr><tr><td>Correlation (n=95)</td><td>Automatic post-dilution : 79 mg/dl Y = 0.96 x - 0.12 with a correlation coefficient r2 = 0.996.</td></tr><tr><td>Calibration stability</td><td>1 day</td></tr><tr><td>Reagent stability</td><td>closed stability: 36 months at 2-8°C</td></tr><tr><td></td><td>on-board stability (refrigerated area): 7 days</td></tr></table>

#

<table><tr><td colspan="2">ABX PENTRA Iron CP :</td></tr><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>7.42 μg/dl</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 3.61%</td></tr><tr><td>Measuring range</td><td>7.42 µg/dl − 1004 µg/dl Automatic post-dilution : 5020 μg/dl</td></tr><tr><td>Correlation (n=98)</td><td>Y = 1.13 x + 5.30 with a correlation coefficient r2 = 0.997.</td></tr><tr><td>Calibration stability</td><td>8 days</td></tr><tr><td>Reagent stability</td><td>closed stability: 24 months at 2-8°C on-board stability (refrigerated area): 41 days</td></tr></table>

# ABX PENTRA Magnesium RTU :

<table><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>0.17 mg/dl</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 3.19%</td></tr><tr><td>Measuring range</td><td>0.17 mg/di − 4.64 mg/dl</td></tr><tr><td></td><td>Automatic post-dilution : 13.92 mg/dl</td></tr><tr><td>Correlation (n=75)</td><td>Y = 1.23 x - 0.24 with a correlation coefficient r2 = 0.971.</td></tr><tr><td>Calibration stability</td><td>2 days</td></tr><tr><td>Reagent stability</td><td>closed stability: 24 months at 2-8°C on-board stability (refrigerated area): 7 days</td></tr></table>

# ABX PENTRA Phosphorus CP :

<table><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>0.28 mg/dl</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 3.56%</td></tr><tr><td>Measuring range</td><td>0.28 mg/dl - 24.18 mg/dl</td></tr><tr><td></td><td>Automatic post-dilution : 96.72 mg/dl</td></tr><tr><td>Correlation (n=105)</td><td>Y = 1.04 x + 0.19 with a correlation coefficient r2 = 0.997.</td></tr><tr><td colspan="2">ABX PENTRA Phosphorus CP :</td></tr><tr><td>Calibration stability</td><td>34 days</td></tr><tr><td>Reagent stability</td><td>closed stability: 36 months at 2-8°C on-board stability (refrigerated area): 34 days</td></tr></table>

# ABX PENTRA Urea CP :

<table><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>Urea: 1.86 mg/dl BUN: 0.9 mg/dl</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 2.76%</td></tr><tr><td rowspan="3">Measuring range</td><td>Urea : 1.86 mg/dl  300 mg/dl</td></tr><tr><td>Automatic post-dilution: 1500 mg/dl</td></tr><tr><td>BUN: 0.9 mg/d1 - 140.3 mg/dl Automatic post-dilution : 701.5 mg/dl</td></tr><tr><td rowspan="2">Correlation (n=108)</td><td>Urea: Y = 1.01 x + 1.80 with a correlation coefficient r2 =</td></tr><tr><td>0.9905. BUN: Y = 1.01 x + 0.81 with a correlation coefficient r2 = 0.9905.</td></tr><tr><td>Calibration stability</td><td>8 days</td></tr><tr><td>Reagent stability</td><td>closed stability: 24 months at 2-8°C</td></tr><tr><td></td><td>on-board stability (refrigerated area): 70 days</td></tr></table>

# ABX PENTRA Uric Acid CP :

<table><tr><td>Sample type</td><td>Serum &amp; plasma</td></tr><tr><td>Detection limit</td><td>0.19 mg/dl</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 2.81%</td></tr><tr><td>Measuring range</td><td>0.19 mg/dl - 25 mg/dl Automatic post-dilution : 75 mg/dl</td></tr><tr><td>Correlation (n=98)</td><td>Y = 0.97 x - 0.13 with a correlation coefficient r2 = 0.958.</td></tr><tr><td>Calibration stability</td><td>15 days</td></tr><tr><td></td><td>closed stability: 36 months at 2-8°C</td></tr><tr><td>Reagent stability</td><td>on-board stability (refrigerated area): 41 days</td></tr><tr><td colspan="2">ABX PENTRA CO2 Cal:</td></tr><tr><td>Stability</td><td>closed stability: 15 months at 2-25°C open stability: 3 months at 2-25°C</td></tr></table>

<table><tr><td colspan="2">ABX PENTRA Multical:</td></tr><tr><td>Stability</td><td>Closed stability: 24 months at 2-8°C Open stability:</td></tr><tr><td></td><td>Once opened, the calibrator components* are stable for :</td></tr><tr><td></td><td>8 hours at 15°C to 25°C</td></tr><tr><td></td><td>2 days at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at -25°C to -15°C</td></tr><tr><td></td><td>*Exceptions</td></tr><tr><td></td><td>Direct Bilirubin</td></tr><tr><td></td><td>3 hours at 15°C to 25°C</td></tr><tr><td></td><td>8 hours at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at 25°C to -15°C</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td>Total Bilirubin</td></tr><tr><td></td><td>6 hours at 15°C to 25°C</td></tr><tr><td></td><td></td></tr><tr><td></td><td>1 day at 2°C to 8°C 2 weeks at −25°C to -15°C</td></tr></table>

# CONTROLS

<table><tr><td colspan="2">ABX PENTRA CO2 Control:</td></tr><tr><td>Stability</td><td>Closed stability: 15 months at 2-25°C Open stability: 3 months at 2-25°C</td></tr></table>

<table><tr><td>ABX PENTRA N Control: Stability Closed stability: 30 months at 2-8°C</td></tr><tr><td>Open stability: Once opened, the control components* are stable for : 12 hours at 15°C to 25°C</td></tr><tr><td colspan="2">ABX PENTRA N Control:</td></tr><tr><td></td><td>Total Bilirubin 8 hours at 15°C to 25°C 1 day at 2°C to 8°C 2 weeks at -25°C to -15°C</td></tr></table>

<table><tr><td colspan="2">ABX PENTRA P Control:</td></tr><tr><td>Stability</td><td>Closed stability: 30 months at 2-8°C Open stability:</td></tr><tr><td></td><td>Once opened, the control components* are stable for :</td></tr><tr><td></td><td>12 hours at 15°C to 25°C</td></tr><tr><td></td><td>5 days at 2°C to 8°C</td></tr><tr><td></td><td>1 month at -25°C to -15°C</td></tr><tr><td></td><td></td></tr><tr><td></td><td>*Exceptions Direct Bilirubin</td></tr><tr><td></td><td>4 hours at 15°C to 25°C</td></tr><tr><td></td><td>8 hours at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at −25°C to -15°C</td></tr><tr><td></td><td></td></tr><tr><td></td><td>Total Bilirubin</td></tr><tr><td></td><td>8 hours at 15°C to 25°C</td></tr><tr><td></td><td>1 day at 2°C to 8°C</td></tr><tr><td></td><td>2 weeks at 25°C to -15°C</td></tr></table>

# Conclusions for Performance Testing :

The performance testing data conclude that the safety and effectiveness of the devices are not compromised, and that they met all acceptance criteria, demonstrating that the devices are substantially equivalent to their respective predicate devices.

Mr. Tim Lawton   
Regulatory Affairs Manager   
Horiba ABX   
Parc Euromèdecine   
Rue du Caducèe- BP 7290   
34184 Montpellier cedex 4- France

# JUL 2 1 2006

Re: k060205 Trade/Device Name: General Chemistries on ABX PENTRA 400 Clinical Chemistry Analyzer ABX PENTRA $\mathrm { C O } _ { 2 }$ Cal ABX PENTRA $\mathrm { C O } _ { 2 }$ Control Regulation Number: 21 CFR $\ S$ 862.1050 Regulation Name: Alkaline phosphatase or isoenzymes test system Regulatory Class: Class II Product Code: CJE, CIC, KHS, CGX, JIY, JGJ, CEO, CDQ, KNK, JJX, JJY, JIX, JIT Dated: June 28, 2006 Received: June 30, 2006

Dear Mr. Lawton:

We have revicwcd your Section 510(k) premarkct notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for usc stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassificd in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (scc above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Codc of Fcderal Regulations (CFR), Parts 800 to 895. In addition, FDA nay publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complics with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2 -

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Interet address   
http://www.fda.gov/cdrh/industry/supporl/index.html.

Sincerely yours,

![](images/a648c1e03a8cfffc5585fff3b5f8cebacb991995bbba6cba08ef3dc096df33af.jpg)

Alberto Gutierez, Ph.D.   
Director   
Division of Chemistry and Toxicology   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number (f o: 060205

Device Name: General Chemistries on ABX PENTRA 400 Clinical Chemistry Analyzer

Indications For Use:

General Chemistries reagents, with associated calibrators and controls, are intended for use on ABX PENTRA 400 Clinical Chemistry Analyzer to measure a variety of analytes.

ABX PENTRA ALP CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of alkaline phosphatase in human serum and plasma based on a kinetic photometric test using p-Nitrophenylphosphate. Measurements of alkaline phosphatase or its isoenzymes are used in the diagnosis and treatment of liver, bone, parathyroid, and intestinal diseases.

ABX PENTRA Calcium CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of calcium in human serum and plasma based on a photometric test using orthocresolphtalein complexone. Calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany (intermittent muscular contractions or spasms).

ABX PENTRA $\mathsf { C O } _ { 2 }$ RTU reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of carbon dioxide in human serum and plasma based on an enzymatic test using phosphoenolpyruvate (PEP),

hosphorenolpyruvate carboxylase (PEPC) and an analog of NADH

Bicarbonate/carbon measurements are used in the diagnosis and treatment of numerous potentially serious disorders associated with changes in body acid-base balance.

Prescription Use X AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD) Page 1 of Afice of in Vutro Dagnostic Devkee on and Safety K0G0205

# Indications for Use

510(k) Number f known 0602u5

Device Name: General Chemistries on ABX PENTRA 400 Clinical Chemistry Analyzer

Indications For Use:

ABX PENTRA Creatinine CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of creatinine in human serum and plasma based on a kinetic method using alkaline picrate (Jaffé method). Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis, and as a calculation basis for measuring other urine analytes.

ABX PENTRA Iron CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of iron (non-heme) in human serum and plasma based on a photometric test (Ferene method). Iron (non-heme) measurements are used in the diagnosis and treatment of diseases such as iron deficiency anemia and hemochromatosis.

ABX PENTRA Magnesium RTU reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of magnesium in human serum and plasma based on a photometric test using xylidyl blue. Magnesium measurements are used in the diagnosis and treatment of hypomagnesemia (abnormally low plasma levels of magnesium) and hypermagnesemia (abnormally high plasma levels of magnesium).

# Indications for Use

510(k) Number (f known):0205

Device Name: General Chemistries on ABX PENTRA 400 Clinical Chemistry Analyzer

Indications For Use:

ABX PENTRA Phosphorus CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of phosphorus in human serum and plasma based on a UV method using phosphomolybdate. Measurement of phosphorus (inorganic) are used in the diagnosis and treatment of various disorders, including parathyroid gland and kidney diseases, and vitamin D imbalance.

ABX PENTRA Urea CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of urea / urea nitrogen (an end-product of nitrogen metabolism) in human serum and plasma based on an enzymatic UV test using urease and glutamate dehydrogenase. Measurements obtained by this device are used in the diagnosis and treatment of certain renal and metabolic diseases.

ABX PENTRA Uric Acid CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of uric acid in human serum and plasma based on the enzymatic determination of uric acid using a chromogenic system in the presence of peroxidase and uricase (Trinder method). Measurements obtained by this device are used in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and of patients receiving cytotoxic drugs.

# Indications for Use

510(k) Number (f known):0025

Device Name: ABX PENTRA CO2 Cal

Indications For Use:

The ABX PENTRA CO2 Cal is a calibrator for use in the calibration of quantitative Horiba ABX PENTRA CO2 RTU method on Horiba ABX clinical chemistry analyzers as specified on the vial.

# Indications for Use

510(k) Nuer (fk: 060205

Device Name: ABX PENTRA CO Control

Indications For Use:

The ABX PENTRA CO2 Control is for use in quality control by monitoring accuracy and precision for the quantitative ABX PENTRA $\complement \mathsf { O } _ { 2 }$ RTU method as specified in enclosed annex.